Medicinova Inc MNOV

NAS: MNOV | ISIN: US58468P2065 14/11/2024

1,830 USD (-8,50%)

(-8,50%) 14/11/2024

Grafiek Medicinova Inc

Grafiek Medicinova Inc

1 dag1d -8,50%
1 week1w 19,61%
1 maand1m 1,10%
3 maanden3m 57,76%
6 maanden6m 22,82%
1 jaar1j 3,98%
5 jaar5j -76,69%

Medicinova Inc in het nieuws

Toon enkel gratis nieuws

9 maart 2021 · MediciNova Announces Partnership with BARDA to Develop MN-166 (ibudilast) as a Medical Countermeasure Against Chlorine Gas-induced Lung Injury · Persbericht

8 maart 2021 · MediciNova to Participate in M Vest LLC and Maxim Group LLC Inaugural Emerging Growth Virtual Conference · Persbericht

3 maart 2021 · MediciNova Announces Update on SARS-CoV-2 Vaccine for COVID-19 · Persbericht

1 februari 2021 · MediciNova Announces Closing of US$20 Million Private Placement Transaction · Persbericht

19 januari 2021 · MediciNova Receives Notice of Allowance for New Patent Covering the Combination of MN-166 (ibudilast) and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan · Persbericht

12 januari 2021 · MediciNova Enters into US$20 Million Securities Purchase Agreement with a fund managed by 3D Investment Partners · Persbericht

Profiel Medicinova Inc

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe